Format

Send to

Choose Destination
Urol Oncol. 2012 Sep;30(5):747. doi: 10.1016/j.urolonc.2012.06.008.

Commentary on "denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomized, placebo-controlled trial." M.R. Smith, F. Saad, R. Coleman, N. Shore, K. Fizazi, B. Tombal, K. Miller, P. Sieber, L. Karsh, R. Damião, T.L. Tammela, B. Egerdie, H. Van Poppel, J. Chin, J. Morote, F. Gómez-Veiga, T. Borkowski, Z. Ye, A. Kupic, R. Dansey, C. Goessl, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.: Lancet 2012;379:39-46 [Epub;2011, November 15].

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center